Fully Automated QuEChERS System Receives U.S. Patent, Laying the Foundation for Global Market Expansion
Recently, the patent for HRHINS Fully Automated QuEChERS System was successfully granted by the United States Patent and Trademark Office (USPTO). This milestone marks international recognition of our R&D innovation and technical expertise, further solidifying our leading position in the field of laboratory automation instrumentation.
The U.S. patent examination process is known for its stringent standards, complex application procedures, detailed documentation requirements, and high filing and maintenance fees. Compared to domestic patent applications, obtaining a U.S. patent is considerably more challenging and demands greater effort from applicants.

U.S. Patent Certificate
This international patent authorization covers our independently developed "Fully Automated QuEChERS System," which automates the entire QuEChERS workflow, significantly improving the efficiency of sample preparation for pesticide residue detection. The patent not only affirms our technological innovation capabilities but also represents a key milestone in our internationalization strategy.
Compared to similar products both domestically and internationally, our Fully Automated QuEChERS System offers distinct advantages in functional versatility, performance stability, operational efficiency, and timely technical support. It has earned wide recognition from customers and has been adopted by numerous authoritative testing institutions, including eurofins Technology Service (QINGDAO) Co., Ltd., eurofins Sac Ky Hai Dang Co., Ltd, Centre Testing International (Qingdao) Co., Ltd., Shenzhen CTT Technology Co., Ltd., Shenzhen Academy of Metrology and Quality Inspection, Fujian Inspection and Research Institute for Product Quality (FQII), Beijing Agro-product Quality Testing Center, and Suzhou Institute for Food Control, etc.
We have participated in major international exhibitions such as Pittcon 2024 and IAFP 2024 (U.S. Food Safety Annual Meeting). At these events, attendees showed great interest in our product's outstanding performance, innovative technology, and ability to address industry pain points. Many visitors engaged in in-depth discussions with our team, inquiring about detailed specifications, pricing strategies, after-sales services, and other aspects, and expressed strong interest—providing a promising start for our international market development.
![]() |
|
| Pittcon 2024 | IAFP 2024 |
HRHINS is a national high-tech enterprise, a National Specialized and Sophisticated "Little Giant" Enterprise, a National Intellectual Property Demonstration Enterprise, and a Beijing Municipal Enterprise-level R&D Institution. We also hold significant roles in multiple authoritative organizations, including the Chinese Society of Toxicology. The company places high priority on independent innovation, and to date, we have been granted 37 domestic invention patents, 156 utility model patents, 21 design patents, and 35 software copyrights. In addition, HRHINS has undertaken numerous national, provincial, and municipal research projects, demonstrating our strong scientific research capabilities and innovative strength.
The acquisition of this foreign patent represents a major step forward in our international journey. Seizing this opportunity, we will continue to increase R&D investment, drive technological innovation, and enhance the global competitiveness of our products, providing customers worldwide with superior, efficient products and services.


